Investigation on the Surgical Treatment Effect of Periprosthetic Femur Fracture After Hip Arthroplasty
NCT ID: NCT03358186
Last Updated: 2017-11-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
155 participants
OBSERVATIONAL
2018-03-01
2019-07-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
revision of periprosthetic fracture
patients with surgically treated periprosthetic femur fracture
surgically treated periprosthetic femur fracture
patients with surgically treated periprosthetic femur fracture
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
surgically treated periprosthetic femur fracture
patients with surgically treated periprosthetic femur fracture
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
55 Years
85 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Peking University People's Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
pengzhang
Department of orthopaedics and trauma
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Peng Zhang, MD
Role: PRINCIPAL_INVESTIGATOR
Peking University People's Hospital
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
csg-pffh
Identifier Type: -
Identifier Source: org_study_id